Diagnostyka Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	2,061	1,950	1,588
Revenue Growth (YoY)	-	22.81%	-
Cost of Revenue	481.95	472.43	401.71
Gross Profit	1,579	1,478	1,186
Selling, General & Admin	1,035	961.54	773.99
Other Operating Expenses	42.71	38.52	35.06
Operating Expenses	1,247	1,161	959.44
Operating Income	332.37	316.89	226.83
Interest Expense	-58.68	-56.06	-54.2
Interest & Investment Income	1.03	3.69	2.01
Earnings From Equity Investments	1.64	1.61	0.06
Currency Exchange Gain (Loss)	-0.06	-0.07	-
Other Non Operating Income (Expenses)	6.56	6.58	-1.55
EBT Excluding Unusual Items	282.86	272.64	173.16
Gain (Loss) on Sale of Investments	12.05	12.05	-4.98
Gain (Loss) on Sale of Assets	4.1	4.1	3.53
Legal Settlements	0.31	0.31	-0.15
Other Unusual Items	2.1	2.1	2.07
Pretax Income	301.41	291.19	173.62
Income Tax Expense	60.65	59.24	43.63
Earnings From Continuing Operations	240.76	231.96	129.99
Minority Interest in Earnings	-8.8	-8.63	-6.56
Net Income	231.96	223.33	123.43
Net Income to Common	231.96	223.33	123.43
Net Income Growth	-	80.93%	-
Shares Outstanding (Basic)	34	34	34
Shares Outstanding (Diluted)	34	34	34
EPS (Basic)	6.87	6.62	3.66
EPS (Diluted)	6.87	6.62	3.66
EPS Growth	-	80.93%	-
Free Cash Flow	316.39	282.72	254.66
Free Cash Flow Per Share	9.37	8.38	7.54
Dividend Per Share	3.310	3.310	-
Gross Margin	76.62%	75.78%	74.70%
Operating Margin	16.13%	16.25%	14.28%
Profit Margin	11.25%	11.45%	7.77%
Free Cash Flow Margin	15.35%	14.50%	16.04%
EBITDA	391.77	368.1	275.58
EBITDA Margin	19.01%	18.88%	17.35%
D&A For EBITDA	59.39	51.21	48.75
EBIT	332.37	316.89	226.83
EBIT Margin	16.13%	16.25%	14.28%
Effective Tax Rate	20.12%	20.34%	25.13%
Revenue as Reported	2,084	1,975	1,597

Source: S&P Global Market Intelligence. Standard template. Financial Sources.